Loading...

Curaleaf Holdings, Inc.

CURA.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$5.22
CA$0.44(9.21%)

Curaleaf Holdings, Inc. CURA.CN Peers

See (CURA.CN) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
CURA.CNCA$5.22+9.21%4.1B-6.07-CA$0.86N/A
BHC.TOCA$8.83+1.03%3.3B-55.19-CA$0.16N/A
VRNO.CNCA$6.32+6.76%2.2B-5.40-CA$1.17N/A
GTII.CNCA$7.19-0.96%1.7B24.79CA$0.29N/A
CRON.TOCA$2.60-0.38%1B13.68CA$0.19N/A
TRUL.CNCA$4.81-2.63%911.7M-4.50-CA$1.07N/A
CURA.TOCA$1.10-4.35%833.4M-2.47-CA$0.45N/A
TER.CNCA$2.38-0.42%804.8M-1.33-CA$1.79N/A
DHT-UN.TOCA$13.40+0.15%748.6M335.00CA$0.04+3.76%
GUD.TOCA$5.75+0.00%572.9M57.50CA$0.10N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

CURA.CN vs BHC.TO Comparison

CURA.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CURA.CN stands at 4.1B. In comparison, BHC.TO has a market cap of 3.3B. Regarding current trading prices, CURA.CN is priced at CA$5.22, while BHC.TO trades at CA$8.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CURA.CN currently has a P/E ratio of -6.07, whereas BHC.TO's P/E ratio is -55.19. In terms of profitability, CURA.CN's ROE is -0.25%, compared to BHC.TO's ROE of +0.03%. Regarding short-term risk, CURA.CN is more volatile compared to BHC.TO. This indicates potentially higher risk in terms of short-term price fluctuations for CURA.CN.

Stock Price Comparison

Loading...

Frequently Asked Questions

;